John Baird, MD
Internal Medicine · Glen Ellyn, ILNPI 1851555619
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $159 of the $220 with a category attached, or 72.5%. Every reported general payment came from a single manufacturer, Boston Scientific.
Across 2 payments — averaging $109.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$220
Across 34 payments — averaging $21,086 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$717K
What the payments were for
- Travel & lodging$6128%
- Food & beverage$15972%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 2 | $220 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Watchman$159
How this compares
$220 in reported general payments places this provider in the 55th percentile of 5,182 internal medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 107 | $158,288 |
| TrulicityDulaglutide | 75 | $123,902 |
| EliquisApixaban | 109 | $97,853 |
| OzempicSemaglutide | 62 | $84,175 |
| JardianceEmpagliflozin | 48 | $67,966 |
| XareltoRivaroxaban | 31 | $42,149 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $16,912 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $16,607 |
| MyrbetriqMirabegron | 14 | $7,406 |
| Atorvastatin Calcium | 663 | $6,771 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $5,409 |
| Metoprolol Succinate | 202 | $4,126 |
| Octreotide Acetate | 26 | $3,988 |
| Olmesartan-Amlodipine-HctzOlmesartan/Amlodipin/Hcthiazid | 34 | $3,901 |
| Levothyroxine Sodium | 277 | $3,481 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Glen Ellyn
- Zaid JabbarOak Brook$1.2M
- Merle DiamondChicago$1.1M
- David ReckerLibertyville$868K
- Yazen JoudehOrland Park$661K
- Robert KushnerChicago$516K
- William CruikshankOak Lawn$431K
- Romeo UrsuaChicago$420K
- Shaina RozellChicago Ridge$366K
- Kristi Tough DesapriWinnetka$344K
- Peter O DonnellChicago$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.